Chosa Oncology
0.89 SEK
0.00 %
Less than 1K followers
CHOSA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
0.00 %
+5.80 %
-1.22 %
-5.89 %
-28.48 %
+36.25 %
-26.06 %
-94.90 %
-92.91 %
Chosa Oncology is a Swedish-Danish biotechnology company that develops solutions for personalized cancer treatment with a focus on diagnostics and drug formulation. The company targets healthcare providers and research actors and works internationally with partners and clinical projects. Chosa Oncology was founded in 2022 and is headquartered in Lund, Sweden.
Read moreMarket cap
78.55M SEK
Turnover
87.61 SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/5
2026
General meeting '26
30/5
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
Chosa Oncology AB: CHOSA Oncology partners with Mount Sinai, New York to test biomarker guiding platin-immunotherapy in lung cancer
Notice of annual general meeting in Chosa Oncology AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools